The Food and Drug Administration (FDA) on March 17 published a final guidance on reprocessing reusable medical devices. This guidance, which provides manufacturers with recommendations to validate their reprocessing instructions, comes on the heels of a host of “superbug” bacteria outbreaks related to reprocessing of endoscopic retrograde cholangiopancreatography (ERCP) duodenoscopes.
It is no long best practice to deliver education via…
Effective communication is the foundation of patient safety in the…
Takeaways • Determining the return on investment (ROI) for a…
Free Daily News